NCT04253327Completed
Distress, Anxiety and Psychosexual Health in BOT
Impact of Diagnosis and Surgical Treatment of Borderline Ovarian Tumors on Distress, Anxiety and Psychosexual Health
Source: ClinicalTrials.gov · Last updated 4 May 2026
Brief summary (registry, in English)
The aim of this study is to assess the prevalence of distress, anxiety and psychosexual anguish in patients diagnosed with borderline ovarian tumor (BOT) compared to controls confronted with surgical treatment for benign ovarian tumors.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 27 Jan 2020
- Start date
- 1 Sept 2020
- Primary completion date
- 1 Feb 2024
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Diseases
- Ovarian cancer
- NCT number
- NCT04253327
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 1 Sept 2020 to the primary completion date, 1 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of another cancer type.
Other
- Known former psychological morbidity evaluated by the investigators.
Who the study is looking for
- Diagnosis and surgery for benign or borderline ovarian tumors.
- \>18 y.
Age in the registry: 18 years to 100 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis UZBrussel Coordinator of this site? Confirm its status | Jette | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.